$6.64
1.48% yesterday
Nasdaq, Apr 04, 10:01 pm CET
ISIN
US53228F1012
Symbol
LFST

LifeStance Health Group Inc Stock price

$6.64
-1.38 17.21% 1M
-0.27 3.91% 6M
-0.73 9.91% YTD
+0.63 10.48% 1Y
-3.92 37.12% 3Y
-15.26 69.68% 5Y
-15.26 69.68% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.10 1.48%
ISIN
US53228F1012
Symbol
LFST
Sector

Key metrics

Market capitalization $2.55b
Enterprise Value $2.88b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 33.66
EV/Sales (TTM) EV/Sales 2.31
P/S ratio (TTM) P/S ratio 2.04
P/B ratio (TTM) P/B ratio 1.76
Revenue growth (TTM) Revenue growth 18.50%
Revenue (TTM) Revenue $1.25b
EBIT (operating result TTM) EBIT $-31.06m
Free Cash Flow (TTM) Free Cash Flow $85.69m
Cash position $154.57m
EPS (TTM) EPS $-0.15
P/E forward negative
P/S forward 1.80
EV/Sales forward 2.04
Short interest 9.44%
Show more

Is LifeStance Health Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

LifeStance Health Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a LifeStance Health Group Inc forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a LifeStance Health Group Inc forecast:

Buy
71%
Hold
29%

Financial data from LifeStance Health Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,251 1,251
19% 19%
100%
- Direct Costs 920 920
10% 10%
74%
331 331
50% 50%
26%
- Selling and Administrative Expenses 292 292
11% 11%
23%
- Research and Development Expense - -
-
-
40 40
137% 137%
3%
- Depreciation and Amortization 71 71
12% 12%
6%
EBIT (Operating Income) EBIT -31 -31
83% 83%
-2%
Net Profit -57 -57
69% 69%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about LifeStance Health Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeStance Health Group Inc Stock News

Neutral
Seeking Alpha
about one month ago
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name i...
Neutral
PRNewsWire
about one month ago
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer.
Neutral
GlobeNewsWire
about one month ago
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
More LifeStance Health Group Inc News

Company Profile

Lifestance Health Group, Inc. operates a holding company. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Head office United States
CEO David Bourdon
Employees 10,218
Founded 2017
Website lifestance.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today